Whilst TNF-alpha is a recognised potent trigger of inflammation in IBD, it is also believed to play a role in the metabolic syndrome with data suggesting it impairs insulin signalling, leading to insulin-resistant states [24–26]. This evidence concerns the gene INS and metabolic syndrome.